SNTS: After it got hit by earnings, if you have nt already got SNTS, this is a good time start a new position if you want to have some fun.
SYMC: A very good opportunity to get in. Looking at the call volume for the January 2011, $20 calls, it seems like price might definitely go up in near future to over 19 and then hang about there.
Will round up with a couple of energy plays TSO (get in around the 14's) , EGY (wait for pull back) and one retail play: Target (TGT) (any time before Xmas is a good time).
November 9, 2010
November 5, 2010
STOCK WATCH: SNTS CLDX INCY ISIS
Watch out for these pharma/biotech stocks to show increasing activity in the next couple of months.
SNTS: Has fair amount of cash on hand ($100 million), low debt, great pipeline and good revenue (2009- $180 million). The company also has a low float so any positive action would trigger large increases in price due to short covering. Also the possibility of a takeover is quite high.
CLDX: Although PFE snapped ties with CLDX, there is a likelihood that some other pharma company might snap it up! They have sufficient cash on hand to go forward for now. (speculative play - depending on their trials etc)
INCY: This stock has been doing quite well on a technical basis and performing on its own right as a pharma company. Look to INCY climbing after earnings and also toaround well over $25 by the end of the year.
ISIS: Receiving payments and royalties on a regular basis, ISIS has been a steady performer, with recent partnerships with GSK and also (Regulus with Sanofi) ISIS is a strong player in the mRNA market. ISIS did two positive Phase 3 studies of mipomersen in the past year and once that drug (Sold by Genzyme) gets marketing approval, the royalty payments would increase. For technical traders, if ISIS breaks 10 and holds, then there can be significant upside.
SNTS: Has fair amount of cash on hand ($100 million), low debt, great pipeline and good revenue (2009- $180 million). The company also has a low float so any positive action would trigger large increases in price due to short covering. Also the possibility of a takeover is quite high.
CLDX: Although PFE snapped ties with CLDX, there is a likelihood that some other pharma company might snap it up! They have sufficient cash on hand to go forward for now. (speculative play - depending on their trials etc)
INCY: This stock has been doing quite well on a technical basis and performing on its own right as a pharma company. Look to INCY climbing after earnings and also to
ISIS: Receiving payments and royalties on a regular basis, ISIS has been a steady performer, with recent partnerships with GSK and also (Regulus with Sanofi) ISIS is a strong player in the mRNA market. ISIS did two positive Phase 3 studies of mipomersen in the past year and once that drug (Sold by Genzyme) gets marketing approval, the royalty payments would increase. For technical traders, if ISIS breaks 10 and holds, then there can be significant upside.
November 4, 2010
Tesoro Corp (TSO) Oil Refiner Beats on Revenue and Earnings
RATED BUY. Also, this stock is also considered a speculative take over candidate.
Tesoro Corp, (San Antonio HQ), West Coast oil refiner beat consensus estimates on Third quarter 2010 Earnings and Revenue. (link)
Tesoro Corporation (NYSE:TSO - News) today reported third quarter 2010 net earnings of $56 million, or $0.39 per diluted share compared to net earnings of $33 million, or $0.24 per diluted share for the third quarter of 2009. The Company earned $73 million or $0.51 per diluted share for the period before one-time after-tax expenses of $17 million primarily associated with the Anacortes refinery outage.
Third quarter segment operating income was $201 million excluding the one-time items, compared to $137 million in the third quarter a year ago. The increase in operating income was driven by stronger distillate margins, improved feedstock cost and the Company’s improvement initiatives. These benefits were partially offset by decreased gasoline margins and reduced throughput. The reduction in throughput was primarily a result of the continued shut-down of the Anacortes refinery and the planned turnaround of our Hawaii refinery.
For the third quarter, the Tesoro Index gained $1.42 per barrel (/bbl) or 17% from a year ago. West Coast benchmark diesel margins were up more than 50% over last year while gasoline margins were down 7%.
The Company realized all of the index gains and more, capturing a gross margin of $13.28/bbl, which was up $3.69/bbl or 38% from a year ago.
Contributing to the Company’s improved performance relative to the index was an increase in conversion unit utilization which resulted in higher clean product yields. In addition, the Company produced more diesel, capturing the stronger distillate margins and ran more Canadian and South American heavy crudes as the discounts for these crudes widened.
“We are pleased with our third quarter results, even with Anacortes down for the period,” said Greg Goff, President and CEO of Tesoro. “During the quarter we saw improvement in distillate margins in our markets similar to what’s been seen across the country. We attribute this to strong distillate exports, improvements in the U.S. manufacturing sector and increased port activity nationwide. Unfortunately, these increases are not being seen in gasoline margins. While gasoline demand has stabilized, high unemployment in California continues to keep gasoline demand weak.”
Tesoro Corp, (San Antonio HQ), West Coast oil refiner beat consensus estimates on Third quarter 2010 Earnings and Revenue. (link)
Tesoro Corporation (NYSE:TSO - News) today reported third quarter 2010 net earnings of $56 million, or $0.39 per diluted share compared to net earnings of $33 million, or $0.24 per diluted share for the third quarter of 2009. The Company earned $73 million or $0.51 per diluted share for the period before one-time after-tax expenses of $17 million primarily associated with the Anacortes refinery outage.
Third quarter segment operating income was $201 million excluding the one-time items, compared to $137 million in the third quarter a year ago. The increase in operating income was driven by stronger distillate margins, improved feedstock cost and the Company’s improvement initiatives. These benefits were partially offset by decreased gasoline margins and reduced throughput. The reduction in throughput was primarily a result of the continued shut-down of the Anacortes refinery and the planned turnaround of our Hawaii refinery.
For the third quarter, the Tesoro Index gained $1.42 per barrel (/bbl) or 17% from a year ago. West Coast benchmark diesel margins were up more than 50% over last year while gasoline margins were down 7%.
The Company realized all of the index gains and more, capturing a gross margin of $13.28/bbl, which was up $3.69/bbl or 38% from a year ago.
Contributing to the Company’s improved performance relative to the index was an increase in conversion unit utilization which resulted in higher clean product yields. In addition, the Company produced more diesel, capturing the stronger distillate margins and ran more Canadian and South American heavy crudes as the discounts for these crudes widened.
“We are pleased with our third quarter results, even with Anacortes down for the period,” said Greg Goff, President and CEO of Tesoro. “During the quarter we saw improvement in distillate margins in our markets similar to what’s been seen across the country. We attribute this to strong distillate exports, improvements in the U.S. manufacturing sector and increased port activity nationwide. Unfortunately, these increases are not being seen in gasoline margins. While gasoline demand has stabilized, high unemployment in California continues to keep gasoline demand weak.”
July 26, 2010
Indian Ladies Score Commonwealth Game 4x400 m Relay
So proud of these runners!!
Phenomenal adrenaline pumping race!!
Phenomenal adrenaline pumping race!!
July 12, 2010
Spectrum Pharma
If you currently hold Spectrum Pharma, and are looking to get out, you can set some limit sells around $ 4.25-$4.30 range. During a surge it might get filled. On the other hand, you can also sell half at the $4.25 pricing range and hold on to the other half, as current sentiment on it seems positive and it might climb through beyound the 50 day moving average of $ 4.29 and go forward up till $5 and on.
Subscribe to:
Comments (Atom)
